Sebi levies Rs 10 lakh fine on Anand Rathi for flouting stock brokers rules

Sebi levies Rs 10 lakh fine on Anand Rathi for flouting stock brokers rules


In its order, the regulator observed that in 55 instances, there was a short collection of margin/ MTM amounting to Rs 33.16 lakh. | Photo: Shutterstock


Capital markets regulator Sebi on Monday imposed a fine of Rs 10 lakh on brokerage firm Anand Rathi Share and Stock Broker for flouting stock brokers’ rules and other norms.


The order came after the Securities and Exchange Board of India (Sebi) conducted a comprehensive inspection of Anand Rathi Share and Stock Broker Ltd (noticee), a Sebi-registered stock broker of BSE, NSE, MCX and NCDEX, for the period from April 2022 to October 2023.

Click here to connect with us on WhatsApp


Based on the findings of the inspection, the regulator found certain alleged non-compliances of Stock Brokers regulations and circulars issued by Sebi, NSE and BSE.

 


In its order, the regulator observed that in 55 instances, there was a short collection of margin/ MTM amounting to Rs 33.16 lakh.


However, Anand Rathi submitted that there was no margin shortfall, and they are adequately collecting margins from the clients and adhering to the regulatory guidelines.


Further, no supporting documents are submitted by the brokerage firm, therefore, the contention of the noticee is not tenable.


Accordingly, Anand Rathi Share and Stock Broker contravened the stock broker rules, the regulator said.


During an inspection on verification of margin collection and reporting, it was observed that the noticee has passed a penalty for a short collection of upfront margins from clients.


However, no supporting documents were provided by Anand Rathi, thereby violating the Code of Conduct of Stock Brokers regulations.


The markets watchdog also identified that a total number of 10 technical glitches occurred between April 2022 and October 2023, which were not reported to the Multi Commodity Exchange (MCX) by the brokerage house.


As per stock brokers’ rules, brokers will have to inform about the technical glitch to the stock exchanges immediately but not later than 1 hour from the time of occurrence of the disruption.


Anand Rathi was under a statutory obligation to abide by and comply with the provisions of the circulars/directions issued by Sebi and stock exchanges, which it failed to do during the inspection period, the regulator added.


In a separate order, the regulator slapped a penalty of Rs 2 lakh on brokerage house Nirmal Bang Securities for violating stock brokers’ regulations.


The order came after the markets watchdog conducted an inspection in respect of Nirmal Bang Securities Pvt Ltd, a Sebi-registered stock broker.


The thematic inspection of books of account and other documents of Nirmal Bang Securities in the matter of verification of authorised persons was conducted by Sebi officials for the period from April 2022 to May 2023.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

First Published: Sep 30 2024 | 8:05 PM IST



Source link

Piramal Pharma to invest M to expand its Lexington, Kentucky facility

Piramal Pharma to invest $80M to expand its Lexington, Kentucky facility


Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma has unveiled an $80M investment plan to expand its Lexington, Kentucky facility.

The site specializes in sterile compounding, liquid filling, and lyophilization for sterile injectable drug products, playing a vital role in Piramal Pharma Solutions integrated antibody‐drug conjugate development and manufacturing program, ADCelerate. The investment, financed by bank loans and internal accruals, aims to enhance the site’s existing capacity and capabilities to meet the demands of a rapidly growing market.

Click here to connect with us on WhatsApp

With this expansion, Piramal Pharma will strengthen its position as an efficient and reliable global partner for biologic manufacturing, leveraging deep scientific expertise and extensive experience managing complex technical projects.

 

The expansion will equip the Lexington site with an additional 24,000 square feet of manufacturing space, a new laboratory, and state‐of‐the‐art machinery to scale clients’ products effectively. Key additions include a new filling line, two commercial‐size lyophilizers, a special capping machine, and an external vial washer.

Currently, the Lexington site can manufacture 104 product batches per year (utilization at peak levels). Upon completion of the expansion in Q1 of 2027, this capacity will increase to over 240 annual batches.

Powered by Capital Market – Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Sep 30 2024 | 6:48 PM IST



Source link

Hyundai to Swiggy: Sebi nod for IPOs paves way for bumper festival season

Hyundai to Swiggy: Sebi nod for IPOs paves way for bumper festival season



The Securities and Exchange Board of India (Sebi) has given green light to several mega initial public offerings (IPOs) last week, paving the way for bumper launches during the ongoing festival season.  


According to the update on Sebi’s website, Hyundai Motor India, which will be the country’s largest IPO of nearly ~25,000 crore, received the observation letter from the market regulator on September 24.

Click here to connect with us on WhatsApp


The regulator also gave the final observations on the offer documents of Vishal Mega Mart and Swiggy.


Both the companies have opted for the pre-filings or confidential filings route. They will have to make their draft red herring prospectus (DRHP) public before they can launch IPOs.

 


The food delivery aggregator has already filed its updated DRHP. According to the updated DRHP, the company has planned a ~3,750-crore fresh issue along with an offer for sale.


Supermarket player Vishal Mega Mart had in July opted for the confidential filing, making it among the few players apart from Oyo, Swiggy and Tata Play to go through this route where a pre-filing is made.


According to sources, the company aims to mobilise $1 billion (around ~8,400) through the issue.


Mamata Machinery and Acme Solar Holdings received green light from Sebi on September 27. Acme IPO’s size is around ~3,000 crore, with a combination of fresh equity and secondary share sale.


Packaging equipment manufacturer Mamata Machinery’s IPO is entirely a secondary share sale of 7.3 million equity shares.


Four of the five IPOs approved last week saw their applications being processed within the three-month timeline.


Meanwhile, Sebi returned the IPO application of Innovision, a firm which provides skilled workforce for blue-collar profiles.


The firm had filed documents to raise ~315 crore from fresh issuance of shares and has an offer for sale of 1.1 million shares. 

First Published: Sep 30 2024 | 6:44 PM IST



Source link

Piramal Pharma to invest M to expand its Lexington, Kentucky facility

Board of Ipca Laboratories approves consolidation of USA generic formulations biz


At meeting held on 30 September 2024

The Board of Ipca Laboratories at its meeting held on 30 September 2024 has approved entering into the following agreements by Bayshore Pharmaceuticals LLC, USA (Bayshore) (wholly-owned step down subsidiary) with Unichem Laboratories (Unichem India) (subsidiary company) and Unichem Pharmaceuticals (USA) Inc (Unichem USA) (wholly owned subsidiary of Unichem India), so as to integrate and consolidate all the Ipca Group’s USA generic formulations business
under one entity:

a) Sale of all rights, title and interest in the product approvals and all goodwill associated with nine (9) ANDAs owned by Bayshore for US Dollar Two Million Six Hundred Fifty Thousand ($2,650,000) through asset sale agreement subject to necessary consents/ approvals to Unichem India; and

Click here to connect with us on WhatsApp

 

b) Sale of all generic formulations marketing / distribution business of Bayshore in the US market as a going concern through slump sale/transfer of entire business (debt free) and all goodwill associated with the business through business sale agreement for US Dollar
Ten Millions ($10,000,000) to Unichem USA.

Powered by Capital Market – Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Sep 30 2024 | 6:44 PM IST



Source link

No stopping the bulls: Sensex, Nifty record sixth straight quarterly gains

No stopping the bulls: Sensex, Nifty record sixth straight quarterly gains



Equity benchmark indices Sensex and the Nifty managed to log gains of around 7 per cent for the quarter ended September 2024, despite recording their worst single-day fall in two months on Monday.


This was the sixth straight quarterly gain for the domestic equity markets, the longest gaining streak in three years.

Click here to connect with us on WhatsApp


Between June 2020 and September 2021, the markets had gained for six straight quarters during the post-Covid-19 surge, underpinned by stimulus measures taken by global central banks.


During the latest upsurge, the Nifty has rallied nearly 50 per cent, while the Nifty Smallcap 100 and the Nifty Midcap100 indices have more than doubled.

 


However, during the latest quarter, the broader markets underperformed the largecaps as investors shifted focus to more quality-oriented stocks.


Since March 2023, India’s marketcap increased by Rs 216 trillion ($2.59 trillion) in market value, becoming the fourth most valuable market globally after the US, China, and Japan.


The six-quarter winning run for the domestic equities has been supported by strong institutional flows, with foreign portfolio investors (FPIs) pumping in Rs 2.95 trillion and mutual funds (MFs) Rs 3.85 trillion during this period.

chart

First Published: Sep 30 2024 | 6:27 PM IST



Source link

Sebi likely to maintain status quo on largecap stock pool expansion

Sebi likely to maintain status quo on largecap stock pool expansion



The largecap and midcap universe of mutual funds (MFs) is unlikely to expand soon, even as the market capitalisation (mcap) of stocks across various categories continues to grow, according to sources.


Earlier this year, Business Standard reported that the Securities and Exchange Board of India (Sebi) was reviewing the stock categorisation framework that ensures actively-managed equity MFs are true to label.

Click here to connect with us on WhatsApp


The regulator had considered expanding the largecap and midcap universe by adding 25–30 more stocks. Currently, the top 100 stocks by mcap fall under the largecap category, the next 150 stocks are classified as midcaps, and the remainder as smallcaps.

 


“The matter is now in cold storage. When the proposal was last discussed, it was concluded that largecap and midcap funds already have enough flexibility to invest in stocks outside their respective universes,” said a senior MF executive.


Largecap funds can allocate up to 20 per cent of their corpus to smallcap and midcap stocks, while midcap schemes have even greater flexibility, with a limit of 35 per cent.


Emails sent to Sebi and the Association of Mutual Funds in India (Amfi) did not receive a response until the time of going to press.


A few fund houses had advocated for expanding the largecap universe, citing the sharp increase in the mcap of smallcap companies over the past three years, which has greatly improved their liquidity.


The dramatic rise in the mcap of smallcap and midcap stocks is reflected in the surge of largecap and midcap cut-offs during the biannual stock reclassification exercise by Amfi.


The mcap threshold to enter the largecap list, which stood at Rs 25,587 crore in January 2020, surged to over Rs 84,000 crore by July 2024. For midcaps, the threshold more than trebled during the same period to Rs 27,560 crore. This contrasts with the global size interval of Rs 2,500 crore to Rs 16,000 crore for smallcap stocks, according to reports.


The list of largecap, midcap, and smallcap stocks is revised by Amfi every January and July based on the average mcap of the previous six months.


In the next exercise, scheduled for January 2025, the largecap cut-off could surpass the Rs 1 trillion mark. Currently, the mcap of around half a dozen midcap stocks has already exceeded Rs 1 trillion.


The largecap universe, limited to 100 stocks, is the smallest among the three mcap-based categories. This is considered one of the factors contributing to the underperformance of largecap funds compared to their benchmarks.


The small universe, experts suggest, restricts the ability of fund managers to add active weight to their portfolios.

Active weight refers to the percentage of a portfolio that differs from its benchmark.

First Published: Sep 30 2024 | 6:23 PM IST



Source link

YouTube
Instagram
WhatsApp